Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Discover strategies to stay motivated: habit cues, accountability, and simple checks that reinforce budgeting consistency.
11,303 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A CNN media analyst and The Morning Show producer commend Stephen Colbert for his upbeat farewell, highlighting leade...
Greg Abel just sold Berkshire Hathaway's Visa and Mastercard holdings and started a new stake in a stock Warren Buffe...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As consumer debt climbs, a sharp cost comparison shows bankruptcy can wipe out unsecured balances in months, while lo...
As 2026 unfolds, retirees face tax and market challenges. A seasoned advisor outlines a tax-smart playbook for a $2 m...
A large 2024 capital gain can trigger IRMAA surcharges, causing Medicare premiums to surge in 2026. Retirees face hun...
If SpaceX ever hits the public markets, the big question isn’t rocket tech or Starlink alone. It’s whether the compan...
Texas’ GOP Senate runoff pits Sen. John Cornyn against Ken Paxton as Trump weighs in, boosting a race already fueled ...
Planners say the key to retirement security lies in inflation adjusted dividend income, built from steady dividend gr...
Hotels are accelerating AI adoption to streamline operations and personalize experiences, marking a turning point in ...
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...